Warfarin Sodium — Drug Intelligence | 12 EU Trials

Filter these 12 trials by condition, phase, country and more.

Open in Search →

12 Registered trials

9 Recruiting

3 Completed trials

11 Sponsors

16 Countries

Phase III

Phase IV

Phase III: 4 Phase II/III: 1 Phase IV: 7

Oversight events:

1 unexpected event across 1 trial

View oversight register →

Indications tested

Acute myocardial infarction 1 Neurosurgery 1 Intracardiac thrombus 1

Sponsors using this IMP

Rigshospitalet 2 Celgene Corp. 1 Centre Hospitalier De Pau 1 Centre Hospitalier Universitaire De Caen Normandie 1 Centre Hospitalier Universitaire De Nantes 1 Centre Hospitalier Universitaire De Saint Etienne 1 Hospital Universitario Ramon Y Cajal 1 HUS-Yhtymae 1 Karolinska Institutet 1 Odense University Hospital 1 St Antonius Hospital 1

All trials

12 total

Restarting Early versus Later Anticoagulation for Chronic Subdural Hematoma with Atrial Fibrillation (RELACS) Recruiting

2025-521179-29-00 Phase II/III 2 countries HUS-Yhtymae
RandomizEd compariSOn of apixaban versus warfarin in patients with Left VEntricular thrombus after Acute Myocardial Infarction (RESOLVE-AMI)… Recruiting

2024-514416-28-00 Phase IV 2 countries Karolinska Institutet
Safety and efficacy of apixaban versus warfarin in peritoneal dialysis patients with non valvular atrial fibrillation: a randomized controll… Recruiting

2023-507544-37-00 Phase III 1 country Centre Hospitalier Universitaire De Caen Normandie
Short-term interruption versus continuous anticoagulation in colorectal polypectomy. A randomized multicenter investigator-initiated non-inf… Recruiting

2024-512194-27-01 Phase IV 1 country Hospital Universitario Ramon Y Cajal
Can patients with atrial fibrillation discontinue anticoagulant therapy after cardiac surgery: The ATLAAC trial Recruiting

2022-502986-92-00 Phase IV 2 countries Odense University Hospital
DAN-WAR-D - Danish Warfarin-Dialysis Study: Safety and efficacy of warfarin in patients with atrial fibrillation on dialysis -A nationwide p… Recruiting

2022-502500-75-00 Phase IV 1 country Rigshospitalet
Personalized, CT-guided antithrombotic therapy versus lifelong single antiplatelet therapy to reduce thromboembolic and bleeding events in n… Recruiting

2023-504637-42-01 Phase IV 5 countries St Antonius Hospital
Iberdomide Manteinance Versus Lenalidomide Manteinance Therapy Following Autologous Stem Cell Transplant in Participants with NDMM Recruiting

2022-501515-14-00 Phase III 16 countries Celgene Corp.
Best Antithrombotic Therapy in patients with acute Venous ThromboEmbolism while taking antiplatelets: the BAT-VTE Recruiting

2022-500974-33-00 Phase III 1 country Centre Hospitalier Universitaire De Saint Etienne
Management of Anticoagulant Therapy monitored by an implantable device with telecardiology in patients with Acute Coronary Syndrome associat… Ended

2024-515433-15-02 Phase IV 1 country Centre Hospitalier De Pau
Anticoagulant Regimens Given to achieve thrombus regression and reduce clinical Outcomes among patients with Non device-related intra-cardia… Ended

2024-512685-33-00 Phase III 1 country Centre Hospitalier Universitaire De Nimes
The Nordic Aortic Valve Intervention Trial 4 (NOTION-4) Ended

2024-518547-38-00 Phase IV 1 country Rigshospitalet

Showing 1–12 of 12 trials

← All drugs A–Z